Flu vaccine may tame heart inflammation, small study hints

NCT ID NCT06508437

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at whether the flu vaccine can reduce inflammation in people with stable coronary artery disease. Inflammation plays a key role in heart disease progression. The trial involved 47 adults aged 60 and older with stable heart disease, who received the flu vaccine either right away or after a delay. Researchers measured changes in blood markers of inflammation, like C-reactive protein, to see if the vaccine had a direct calming effect on the immune system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chru de Trousseau

    Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.